Skip to main content
Caplight Logo









Hormona

Hormona

Private
LondonHealthcare & Life Scienceshttps://www.hormona.io/

Last Round

Grant

Sep 10, 2025

Total Funding Raised

$8.34M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Hormona is a healthtech company that provides a data-driven platform using AI and at-home testing to help women track, understand, and manage their hormonal health.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, D2C Brands, Healthcare Analytics, Subscription Commerce, Patient Engagement

Business Model

B2C

Customer Profile

Hardware Sales, Subscription SaaS, Freemium

AI Layer

Application

Keywords

femtechat-home hormone testhormone trackingmenstrual healthmenopause supportAI diagnosticsdigital health platformreproductive healthD2C healthperiod trackerhormone imbalancehealth techwellness appbiometric trackingemployee wellness

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hormona Comparables

Compare Hormona with similar companies based on industry and business-model similarity.

Hormona comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Mira
84%
Oova
82%
Superpower
78%

Hormona Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 10, 2025
SeedMay 26, 2025
Pre SeedMay 30, 2022

Key People

Founding team and executive leadership

Jasmine Tagesson

COO Co-founder

Founding Team

Karolina Löfqvist

Founder CEO

Founding Team

Hormona Investors

Notable investors and investment history

Hormona investors
InvestorRounds
TechstarsSeed, Pre Seed
Voima VenturesSeed
DLF VentureSeed
Innovate UKGrant
SFC CapitalPre Seed
Nascent InvestSeed
Supernode GlobalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 17, 2026

    Monthly visitors increased 47% MoM, reaching 44.4K.

  • Sep 10, 2025

    $135K grant received

Hormona Filings

Explore SEC and related filing metadata, where available.

Hormona filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Hormona's valuation, stock price, and market status.

Is Hormona a public or private company?

Hormona is a private company.

What is the current stock price of Hormona?

Hormona is a private company with no public stock price. No recent secondary market data is available.

How much is Hormona worth (valuation)?

Valuation information for Hormona is not publicly available.

Can I buy Hormona stock?

Hormona shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Hormona's last funding round?

Hormona's most recent funding round was Grant on September 10, 2025.

Who are the main investors in Hormona?

Key investors in Hormona include Voima Ventures, Supernode Global.

Will Hormona IPO soon?

No public IPO plans have been announced for Hormona.

How can I track Hormona secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hormona's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range23
Year Founded2020
Last FundingSep 10, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?